🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Syneos Health Clinical Research Services, LLC
Start Date
2025-11-17
Trial ID
NCT07350577
Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg c...
Status
Active Not Recruiting
Location
Kantonsspital Aarau, Neurozentrum
Start Date
2019-06-14
Trial ID
NCT03735901
Treatments Being Tested
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
Randomized, placebo-controlled, double-blind, parallel design, Phase 3 stud...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2009-09
Trial ID
NCT01037244
This is a randomized, double-blind, active drug- and placebo-controlled, do...
Status
Recruiting
Location
The Third Xiangya Hospital of Central South University
Start Date
2026-03-30
Trial ID
NCT07519109
Treatments Being Tested